TNFSF14 |
TNFSF14, HVEML, UNQ391/PRO726, LIGHT: Tumor necrosis factor ligand superfamily m |
CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
2.547 |
Evidence |
|
PKN2 |
PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 |
SGK2 |
SGK2: Serine/threonine-protein kinase Sgk2 |
2.547 |
Evidence |
|
FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
C13orf8 |
IPI00414497 |
2.547 |
Evidence |
|
CSK |
CSK: Tyrosine-protein kinase CSK |
CASP9 |
CASP9, MCH6: Caspase-9 precursor |
2.547 |
Evidence |
|
UACA |
UACA, KIAA1561: Uveal autoantigen with coiled-coil domains and ankyrin repeats |
LYN |
LYN: Tyrosine-protein kinase Lyn |
2.547 |
Evidence |
|
PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
MDGA1 |
MDGA1, MAMDC3: MAM domain-containing glycosylphosphatidylinositol anchor protein |
2.547 |
Evidence |
|
NUP98 |
IPI00337397 |
ELF2 |
ELF2, NERF: ETS-related transcription factor Elf-2 |
2.547 |
Evidence |
|
STAT3 |
|
USP10 |
USP10, KIAA0190: Ubiquitin carboxyl-terminal hydrolase 10 |
2.547 |
Evidence |
|
HIST1H1C |
HIST1H1C, H1F2: Histone H1.2 |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
2.547 |
Evidence |
|
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
NFIA |
NFIA, RP5-902P15.1-003, hCG_2032260: Nuclear factor I/A |
2.547 |
Evidence |
|
PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
SCRIB |
SCRIB, CRIB1, KIAA0147, LAP4, SCRB1, VARTUL: Protein LAP4 |
2.547 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
2.547 |
Evidence |
|
QARS |
QARS: Glutaminyl-tRNA synthetase |
RARS |
RARS: Arginyl-tRNA synthetase, cytoplasmic |
2.542 |
Evidence |
O
|
EIF3S6 |
EIF3S6, INT6: Eukaryotic translation initiation factor 3 subunit 6 |
PSMD11 |
PSMD11: 26S proteasome non-ATPase regulatory subunit 11 |
2.542 |
Evidence |
|
MYH11 |
MYH11, KIAA0866: Myosin-11 |
ACTG2 |
ACTG2, ACTA3, ACTL3, ACTSG: Actin, gamma-enteric smooth muscle |
2.537 |
Evidence |
|
SLC2A2 |
SLC2A2, GLUT2: Solute carrier family 2, facilitated glucose transporter member 2 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
2.537 |
Evidence |
|
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
NTE |
IPI00217600 |
2.535 |
Evidence |
|
PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
CSTF1 |
CSTF1: Cleavage stimulation factor 50 kDa subunit |
2.535 |
Evidence |
|
CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
2.535 |
Evidence |
|
RANBP2 |
RANBP2, NUP358: E3 SUMO-protein ligase RanBP2 |
CHC1 |
RCC1: RCC1-I (Fragment) |
2.535 |
Evidence |
|
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
2.535 |
Evidence |
|
FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
SALL1 |
SALL1, SAL1: Sal-like protein 1 |
2.53 |
Evidence |
|
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
2.53 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
HPCA |
HPCA, BDR2: Neuron-specific calcium-binding protein hippocalcin |
2.53 |
Evidence |
|
AURKA |
AURKA, AIK, ARK1, AURA, BTAK, STK15, STK6: Serine/threonine-protein kinase 6 |
KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
2.525 |
Evidence |
|